ABUS vs UPS
Arbutus Biopharma Corp (ABUS) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the ABUS and UPS stock pages for the full models.
Not investment advice.